Characteristics of Patients With Axial Spondyloarthritis by Geographic Regions: PROOF Multicountry Observational Study Baseline Results (2021)
https://pubmed.ncbi.nlm.nih.gov/34897381/

Development of quality standards for patients with axial spondyloarthritis for use in Germany (2021)
https://pubmed.ncbi.nlm.nih.gov/34379181/

Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysis (2021)
https://pubmed.ncbi.nlm.nih.gov/34187873/

Deep learning for detection of radiographic sacroiliitis: achieving expert-level performance (2021)
https://pubmed.ncbi.nlm.nih.gov/33832519/

Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33796155/

Relation of α 2-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/33317138/

The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study (2020)
https://pubmed.ncbi.nlm.nih.gov/33281952/

The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study (2020)
https://pubmed.ncbi.nlm.nih.gov/32912264/